Literature DB >> 6941380

Comparison of the action of pirenzepine and L-hyoscyamine on gastric acid secretion and other muscarinic effects.

B H Jaup, R W Stockbrügger, G Dotevall.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6941380

Source DB:  PubMed          Journal:  Scand J Gastroenterol Suppl        ISSN: 0085-5928


× No keyword cloud information.
  8 in total

1.  Pharmacokinetic and pharmacodynamic studies in man simulating acute and chronic treatment with oral pirenzepine.

Authors:  W Londong; V Londong; C Federle; P Tanswell; U Voderholzer
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

Review 2.  Newer antisecretory agents for peptic ulcer.

Authors:  K W Somerville; M J Langman
Journal:  Drugs       Date:  1983-03       Impact factor: 9.546

3.  Evaluation of pirenzepine on gastric acidity in healthy volunteers using ambulatory 24 hour intragastric pH-monitoring.

Authors:  A Etienne; C J Fimmel; B A Bron; E Loizeau; A L Blum
Journal:  Gut       Date:  1985-03       Impact factor: 23.059

4.  Identification of muscarinic receptor subtype mediating colonic response to eating.

Authors:  F Narducci; G Bassotti; S Daniotti; P Del Soldato; M A Pelli; A Morelli
Journal:  Dig Dis Sci       Date:  1985-02       Impact factor: 3.199

5.  Effects of H2-receptor antagonists and anticholinoceptor drugs on gastric and salivary secretion induced by bethanechol in the anaesthetized dog.

Authors:  M J Daly; J M Humphray; R Stables
Journal:  Br J Pharmacol       Date:  1982-07       Impact factor: 8.739

Review 6.  The problems of anticholinergic adverse effects in older patients.

Authors:  M Feinberg
Journal:  Drugs Aging       Date:  1993 Jul-Aug       Impact factor: 3.923

7.  Effects of antireflux therapies on salivary function in normal humans.

Authors:  K R DeVault; D O Castell
Journal:  Dig Dis Sci       Date:  1987-06       Impact factor: 3.199

Review 8.  Pirenzepine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in peptic ulcer disease and other allied diseases.

Authors:  A A Carmine; R N Brogden
Journal:  Drugs       Date:  1985-08       Impact factor: 9.546

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.